The collective trauma of the Covid-19 pandemic may provide a clearer understanding of why people use drugs — to help us see it not as a moral failing or a brain malfunction, but as a fundamentally human response to negative life events. Read more at the Baker Institute Blog.
"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.
Baker Institute health policy experts provide links to some of the sources they found helpful in understanding developments in the coronavirus outbreak.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
This paper outlines proposals that integrate economic development and nature to address our region’s flood problems, as well as structural solutions that serve multiple purposes.
Jim Blackburn, Elizabeth Winston-JonesDecember 19, 2019
The authors use survey and interview data to evaluate drug treatment options available through the court diversion process for people charged with drug offenses in Harris County, Texas.
Katharine Neill Harris, Jay JenkinsDecember 10, 2019
Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or convicted of a crime will commit a future offense. Baker Institute Blog: https://bit.ly/2Cwl6jc
This report, produced in collaboration with the University of Houston's Hobby School of Public Affairs, analyzes findings of a survey on Houstonians’ views on the candidates in the Houston mayoral race: http://bit.ly/2PavYL9.
Mark P. Jones, Renee Cross, Richard Murray, Agustín VallejoOctober 20, 2019
Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor, write experts Kenneth M. Evans, Kirstin R.W. Matthews and Daniel Moralí. Baker Institute blog: http://bit.ly/2MDRDbW
Kenneth M. Evans, Kirstin R.W. Matthews, Daniel MoralíOctober 14, 2019